Department of Biological Sciences,
Molecular and Cellular Biology Program,
Edison Biotechnology Institute,
Department of Biomedical Sciences,
Heritage College of Osteopathic Medicine,
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine
Xiaozhuo Chen has not added Biography.
If you are Xiaozhuo Chen and would like to personalize this page please email our Author Liaison for assistance.
A ribozyme-mediated, gene "knockdown" strategy for the identification of gene function in zebrafish.
Proceedings of the National Academy of Sciences of the United States of America Dec, 1997 | Pubmed ID: 9391103
Seryl-histidine as an alternative DNA nicking agent in nick translation yields superior DNA probes and hybridizations.
Bioorganic & medicinal chemistry Mar, 2002 | Pubmed ID: 11814854
Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells.
The Journal of nutrition Feb, 2005 | Pubmed ID: 15671208
Transcription regulation of the vegf gene by the BMP/Smad pathway in the angioblast of zebrafish embryos.
Biochemical and biophysical research communications Apr, 2005 | Pubmed ID: 15721310
Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway.
Biochemical and biophysical research communications Oct, 2005 | Pubmed ID: 16137651
Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues.
Journal of medicinal chemistry May, 2006 | Pubmed ID: 16640344
Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa.
Evidence-based complementary and alternative medicine : eCAM Dec, 2007 | Pubmed ID: 18227906
Regulation of G(1) arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2alpha phosphorylation.
Neoplasia (New York, N.Y.) Jan, 2010 | Pubmed ID: 20072654
Novel inhibitors of basal glucose transport as potential anticancer agents.
Bioorganic & medicinal chemistry letters Apr, 2010 | Pubmed ID: 20194024
Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms.
Cancer letters Dec, 2010 | Pubmed ID: 20678861
Insulin receptor signaling activated by penta-O-galloyl-α-D: -glucopyranose induces p53 and apoptosis in cancer cells.
Apoptosis : an international journal on programmed cell death Sep, 2011 | Pubmed ID: 21671008
A novel small molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose mimics the antiplatelet actions of insulin.
PloS one , 2011 | Pubmed ID: 22073153
A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.
Molecular cancer therapeutics Aug, 2012 | Pubmed ID: 22689530
Synthesis and Antitumor Activity of Ellagic Acid Peracetate.
ACS medicinal chemistry letters Aug, 2012 | Pubmed ID: 23185648
Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
Journal of molecular endocrinology , 2013 | Pubmed ID: 23549408
Constituents of an extract of Cryptocarya rubra housed in a repository with cytotoxic and glucose transport inhibitory effects.
Journal of natural products Mar, 2014 | Pubmed ID: 24344605
Biological and biomedical functions of Penta-O-galloyl-D-glucose and its derivatives.
Journal of natural medicines Jul, 2014 | Pubmed ID: 24532420
Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells.
Cancer letters Sep, 2014 | Pubmed ID: 24973521
The Warburg effect: evolving interpretations of an established concept.
Free radical biology & medicine Feb, 2015 | Pubmed ID: 25277420
Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells.
ChemMedChem Nov, 2015 | Pubmed ID: 26332543
Novel 1,5-diphenyl-6-substituted 1H-pyrazolo[3,4-d]pyrimidin-4(5H)-ones induced apoptosis in RKO colon cancer cells.
Journal of enzyme inhibition and medicinal chemistry Dec, 2016 | Pubmed ID: 26677729
Extracellular ATP a New Player in Cancer Metabolism: NSCLC Cells Internalize ATP In Vitro and In Vivo Using Multiple Endocytic Mechanisms.
Molecular cancer research : MCR 11, 2016 | Pubmed ID: 27578770
Cardiac Glycoside Constituents of Streblus asper with Potential Antineoplastic Activity.
Journal of natural products 03, 2017 | Pubmed ID: 27983842
Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase.
Oncotarget Oct, 2017 | Pubmed ID: 29152126
Extracellular and macropinocytosis internalized ATP work together to induce epithelial-mesenchymal transition and other early metastatic activities in lung cancer.
Cancer cell international , 2019 | Pubmed ID: 31582910
Plant-derived glucose transport inhibitors with potential antitumor activity.
Phytotherapy research : PTR May, 2020 | Pubmed ID: 31823431
Cytotoxic and non-cytotoxic cardiac glycosides isolated from the combined flowers, leaves, and twigs of Streblus asper.
Bioorganic & medicinal chemistry 02, 2020 | Pubmed ID: 31953129
The anti-diabetic effect of eight Lagerstroemia speciosa leaf extracts based on the contents of ellagitannins and ellagic acid derivatives.
Food & function Feb, 2020 | Pubmed ID: 32003379
Na/K-ATPase-Targeted Cytotoxicity of (+)-Digoxin and Several Semisynthetic Derivatives.
Journal of natural products 03, 2020 | Pubmed ID: 32096998
Isosteres of ester derived glucose uptake inhibitors.
Bioorganic & medicinal chemistry letters 09, 2020 | Pubmed ID: 32736210
Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism.
Diabetes, metabolic syndrome and obesity : targets and therapy , 2021 | Pubmed ID: 33658814
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.
Cancer & metabolism Mar, 2021 | Pubmed ID: 33771231
Corinne M. Nielsen*,1,2,3,
Yanrong Qian*,4,
Subhodip Adhicary1,5,
Yunsheng Li4,
Pratik Shriwas1,2,4,
Xuan Wang1,2,4,
Lindsey Bachmann6,
Xiaozhuo Chen1,2,4,7
1Department of Biological Sciences, Ohio University,
2Molecular and Cellular Biology Program, Ohio University,
3Neuroscience Program, Ohio University,
4Edison Biotechnology Institute, Ohio University,
5Translational Biomedical Sciences Program, Ohio University,
6Honors Tutorial College, Ohio University,
7Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University